StemCells (STEM) announces plans to sell more common stock and warrants in an effort to raise funds for product development. The offer comes as a surprise to investors, considering the company effected a 1-for-10 reverse stock split earlier this year as part of an effort to meet Nasdaq listing rules and increase the shares' appeal to investors. Shares -10.7% AH.
StemCells (STEM) announces plans to sell more common stock and warrants in an effort to raise...
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs